Skip to main content
Clinical Trials/NCT07284615
NCT07284615
Not yet recruiting
Not Applicable

Lateral Femoral Cutaneous Nerve (LFCN) Block or Wound Infiltration (WI) Combined With Pericapsular Nerve Group (PENG) Block for Analgesia in Elective Anterior Approach Total Hip Arthroplasty: A Randomized Controlled Trial

Ospedale Edoardo Bassini1 site in 1 country102 target enrollmentStarted: December 1, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Ospedale Edoardo Bassini
Enrollment
102
Locations
1
Primary Endpoint
Pain at rest control at 6h

Overview

Brief Summary

This prospective, randomized controlled trial aims to compare two multimodal regional anesthesia strategies for postoperative analgesia in elective total hip arthroplasty (THA) performed via anterior approach. Patients will be randomized to receive either a Pericapsular Nerve Group (PENG) block combined with a Lateral Femoral Cutaneous Nerve (LFCN) block, or a PENG block combined with wound infiltration (WI).

The primary outcome is postoperative pain intensity at rest, measured by Numerical Rating Scale (NRS) at 6 hours after surgery. Secondary outcomes include dynamic pain scores at 6, 24, and 48 hours, total opioid consumption, time to first rescue analgesia, quadriceps strength, hip flexion angle, length of stay, and adverse events.

All procedures are routinely used in clinical practice and carry minimal additional risk. Safety will be continuously monitored by the Principal Investigator and the study team according to an internal Safety Monitoring Plan.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Masking Description

The anesthetist in the operating room will be the only one who knows what treatment has been administered

Participant: the patient will not know the type of block he will be subjected to, because of he will already be subjected to neuraxial anesthesia.

Outcomes Assessor: a clinician external to the practice will evaluate the degree of residual paralysis after anesthesia and pain control Investigator: the statistician will not know which anesthetic technique was administered to which group

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age \> 18 years
  • Elective total hip arthroplasty
  • Spinal (subarachnoid) anesthesia
  • Written informed consent provided by the patient or by the legal guardian, if appointed

Exclusion Criteria

  • INR \> 1.5
  • aPTT \> 1.5
  • Platelet count \< 75,000/mm³
  • Signs suggestive of infection at the puncture site
  • Absence of informed consent to the procedure
  • Documented or suspected allergy to local anesthetics

Outcomes

Primary Outcomes

Pain at rest control at 6h

Time Frame: six hours after performing the regional anesthesia technique

pain assessment with Numeric Rating Scale (NRS): a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

Secondary Outcomes

  • Pain at rest control at 24h(24 hours after performing the regional anesthesia technique)
  • Pain at rest control at 48h(48 hours after performing the regional anesthesia technique)
  • Pain on movement control at 6h(six hours after performing the regional anesthesia technique)
  • Pain on movement control at 24h(24 hours after performing the regional anesthesia technique)
  • Pain on movement control at 48h(48 hours after performing the regional anesthesia technique)
  • the degree of hip flexion at 24h(24 hours after performing the regional anesthesia technique)
  • the degree of hip flexion at 48h(48 hours after performing the regional anesthesia technique)
  • MRC at 6h(six hours after performing the regional anesthesia technique)
  • MRC at 24h(24 hours after performing the regional anesthesia technique)
  • MRC at 48h(48 hours after performing the regional anesthesia technique)
  • time to first PRN opioid request(Time Frame: From date of surgery until up to 48 hours after)
  • MME of PRN opioid total doses(From date of surgery until up to 48 hours after)
  • Complication(From date of surgery until up to 48 hours after)
  • the degree of hip flexion at 6h(six hours after performing the regional anesthesia technique)
  • Length of Hospital Stay (LOS)(From date of surgery until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 10 months)

Investigators

Sponsor
Ospedale Edoardo Bassini
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Matteo Coccolo

Medical Doctor, Principal Investigator

Ospedale Edoardo Bassini

Study Sites (1)

Loading locations...

Similar Trials